Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats

26Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Over 50% of acute stroke patients have hyperglycemia, which is associated with a poorer prognosis and outcome. Our aim was to investigate the impact of hyperglycemia on behavioral recovery and brain repair of delivered human adipose tissue-derived mesenchymal stem cells (hAD-MSCs) in a rat model of permanent middle cerebral artery occlusion (pMCAO). Methods: Hyperglycemia was induced in rats by the administration of nicotinamide and streptozotocin. The rats were then subjected to stroke by a pMCAO model. At 48 h post-stroke, 1 × 106 hAD-MSCs or saline were intravenously administered. We evaluated behavioral outcome, infarct size by MRI, and brain plasticity markers by immunohistochemistry (glial fibrillary acidic protein [GFAP], Iba-1, synaptophysin, doublecortin, CD-31, collagen-IV, and α-smooth muscle actin [α-SMA]). Results: The hyperglycemic group exhibited more severe neurological deficits; lesion size and diffusion coefficient were larger compared with the non-hyperglycemic rats. GFAP, Iba-1, and α-SMA were increased in the hyperglycemic group. The hyperglycemic rats administered hAD-MSCs at 48 h after pMCAO had improved neurological impairment. Although T2-MRI did not show differences in lesion size between groups, the rADC values were lower in the treated group. Finally, the levels of GFAP, Iba-1, and arterial wall thickness were lower in the treated hyperglycemic group than in the nontreated hyperglycemic group at 6 weeks post-stroke. Conclusions: Our data suggest that rats with hyperglycemic ischemic stroke exhibit increased lesion size and impaired brain repair processes, which lead to impairments in behavioral recovery after pMCAO. More importantly, hAD-MSC administration induced better anatomical tissue preservation, associated with a good behavioral outcome.

References Powered by Scopus

Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct

4104Citations
N/AReaders
Get full text

Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging

3611Citations
N/AReaders
Get full text

Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair - Current views

1655Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges

62Citations
N/AReaders
Get full text

Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective

47Citations
N/AReaders
Get full text

Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gómez-De Frutos, M. C., Laso-Garciá, F., Diekhorst, L., Otero-Ortega, L., Fuentes, B., Jolkkonen, J., … Gutiérrez-Fernández, M. (2019). Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats. Stem Cell Research and Therapy, 10(1). https://doi.org/10.1186/s13287-019-1322-x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

67%

Researcher 5

24%

Professor / Associate Prof. 2

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

42%

Neuroscience 6

23%

Biochemistry, Genetics and Molecular Bi... 6

23%

Agricultural and Biological Sciences 3

12%

Save time finding and organizing research with Mendeley

Sign up for free